← Back to Discover
BML Capital Management, LLC
Period ended Sep 30, 2026 · Latest filing Nov 6, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $187,619,016
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ACLARIS THERAPEUTICS INC · COM · 00461U105 · shares: $57,623,300
- ATEA PHARMACEUTICALS INC · COM · 04683R106 · shares: $35,186,558
- ENGENE THERAPEUTICS INC · COM · 29286X101 · shares: $13,339,816
- PMV PHARMACEUTICALS INC · COM · 69353Y103 · shares: $12,241,100
- KRAFT HEINZ CO · COM · 500754106 · shares: $10,792,000
- TILLYS INC · CL A · 886885102 · shares: $9,954,500
- CARMAX INC · COM · 143130102 · shares: $9,506,475
- OUTSET MED INC · COM NEW · 690145206 · shares: $7,559,103
- TARGET CORP · COM · 87612E106 · shares: $5,875,875
- SEER INC · COM CL A · 81578P106 · shares: $4,876,089
Reported holdings
20 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | — | 10,955,000 shares | $57,623,300 |
| ATEA PHARMACEUTICALS INC | COM | 04683R106 | — | 6,753,658 shares | $35,186,558 |
| ENGENE THERAPEUTICS INC | COM | 29286X101 | — | 6,669,908 shares | $13,339,816 |
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | — | 7,330,000 shares | $12,241,100 |
| KRAFT HEINZ CO | COM | 500754106 | — | 475,000 shares | $10,792,000 |
| TILLYS INC | CL A | 886885102 | — | 2,150,000 shares | $9,954,500 |
| CARMAX INC | COM | 143130102 | — | 172,500 shares | $9,506,475 |
| OUTSET MED INC | COM NEW | 690145206 | — | 2,519,701 shares | $7,559,103 |
| TARGET CORP | COM | 87612E106 | — | 37,500 shares | $5,875,875 |
| SEER INC | COM CL A | 81578P106 | — | 2,186,587 shares | $4,876,089 |
| INSTIL BIO INC | COM NEW | 45783C200 | — | 645,600 shares | $4,674,144 |
| CONNECT BIOPHARMA HLDGS LTD | SHS | G23549101 | — | 3,864,400 shares | $4,250,840 |
| ORAMED PHARMACEUTICALS INC | COM NEW | 68403P203 | — | 884,392 shares | $4,130,111 |
| JANUX THERAPEUTICS INC | COM | 47103J105 | — | 151,126 shares | $2,611,457 |
| PLIANT THERAPEUTICS INC | COM | 729139105 | — | 1,546,137 shares | $1,669,828 |
| LENZ THERAPEUTICS INC | COM | 52635N103 | — | 283,114 shares | $1,087,158 |
| IMAGENEBIO INC | COM | 45175G207 | — | 200,730 shares | $919,343 |
| TESLA INC | COM | 88160R101 | PUT | 150 shares | $696,000 |
| WALMART INC | COM | 931142103 | PUT | 335 shares | $537,675 |
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | — | 71,839 shares | $87,644 |